4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-027005
President & Immunovant CEO sold 100,000 shares at $11.52 ($1,152,000)
- President & Immunovant CEO acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & Immunovant CEO | 2025-07-21 | Option exercise 10b5-1 | +100,000 | $3.85 | $385,000 | 1,562,223 | D |
| Venker Eric President & Immunovant CEO | 2025-07-21 | Sale 10b5-1 | −100,000 | $11.52 | $1,152,000 | 1,462,223 | D |
| Derivatives | |||||||
| Venker Eric President & Immunovant CEO | 2025-07-21 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 8,138,897 | D | ||
| Open-market sales · 100,000 sh · avg $11.52 · $1,152,000 | |||||||
Loading xslF345X05/form4.xml…